Shawn McCormick, Director at Inspire Medical Systems, Inc. (INSP), sold 696 shares at $45.31 ($32K) on 2026-05-08, disclosed to the SEC on 2026-05-11.
Scheduled sale ($32k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INSP | SELL | 2025-05-05 | $58K | — | Filing → |
| INSP | SELL | 2024-09-11 | $176K | — | Filing → |
| NVRO | BUY | 2023-06-09 | $172K | — | Filing → |